F. Lepretre , L. Moreno , A. Joshkon , N. Bardin , M. Blot-Chabaud , P. Chanez , D. Gras
{"title":"Involvement of epithelial CD146 in severe asthma","authors":"F. Lepretre , L. Moreno , A. Joshkon , N. Bardin , M. Blot-Chabaud , P. Chanez , D. Gras","doi":"10.1016/j.rmr.2025.02.049","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Asthma is a chronic lung disease affecting 300 million people worldwide, 2-10 % of whom suffer from severe asthma. In asthma, the bronchial epithelium is dysregulated, contributing to the pathophysiology of the disease. CD<sub>146</sub> is an adhesion molecule that is highly expressed on all the cells from the vascular system, including endothelial cells. It is also expressed by epithelial cells, but its functions in these cells are poorly understood, as is its role in severe asthma. The aim of our study is to elucidate the role of CD<sub>146</sub> in the bronchial epithelium and its implication in severe asthma.</div></div><div><h3>Methods</h3><div>Bronchial epithelia of healthy controls and severe asthma patients were reconstituted in vitro using air-liquid interface culture. Measurements of CD<sub>146</sub> expression were made on differentiated epithelium (n<!--> <!-->=<!--> <!-->20 control and 20 severe asthma patients). Then, undifferentiated and differentiated bronchial epithelial cells were sorted based on the expression level of CD<sub>146</sub>. The sorted undifferentiated bronchial epithelial cells were cultured and monitored during the differentiation process until obtention of a fully differentiated epithelium (n<!--> <!-->=<!--> <!-->3). The sorted differentiated bronchial epithelial cells were used to perform RNA-Seq experiments (n<!--> <!-->=<!--> <!-->4).</div></div><div><h3>Results</h3><div>We showed that CD<sub>146</sub> is highly expressed in severe asthma patients compared to healthy controls both at mRNA and protein levels in differentiated epithelium. Then, we have shown that CD<sub>146</sub> expression is not ubiquitous in the differentiated bronchial epithelium. Cell sorting and RNA-seq experiments demonstrated that CD<sub>146</sub> is mostly expressed by the basal epithelial cells in the differentiated epithelium. Finally, morphological analysis revealed that CD<sub>146</sub> seems to play a role in the bronchial epithelium differentiation process. Indeed, fully differentiated epithelium obtained from CD<sub>146</sub>+ and CD<sub>146</sub>− sorted undifferentiated bronchial epithelial cells were different in morphology and cell composition.</div></div><div><h3>Conclusion</h3><div>Our results suggest that CD<sub>146</sub> is only expressed by basal cells of the bronchial epithelium and supports an important role in the differentiation of this epithelium. Moreover, we demonstrated that CD<sub>146</sub>is overexpressed in severe asthma, suggesting a possible role of this molecule in this disease notably during repair epithelial process.</div></div>","PeriodicalId":21548,"journal":{"name":"Revue des maladies respiratoires","volume":"42 4","pages":"Page 206"},"PeriodicalIF":0.5000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue des maladies respiratoires","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0761842525000920","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Asthma is a chronic lung disease affecting 300 million people worldwide, 2-10 % of whom suffer from severe asthma. In asthma, the bronchial epithelium is dysregulated, contributing to the pathophysiology of the disease. CD146 is an adhesion molecule that is highly expressed on all the cells from the vascular system, including endothelial cells. It is also expressed by epithelial cells, but its functions in these cells are poorly understood, as is its role in severe asthma. The aim of our study is to elucidate the role of CD146 in the bronchial epithelium and its implication in severe asthma.
Methods
Bronchial epithelia of healthy controls and severe asthma patients were reconstituted in vitro using air-liquid interface culture. Measurements of CD146 expression were made on differentiated epithelium (n = 20 control and 20 severe asthma patients). Then, undifferentiated and differentiated bronchial epithelial cells were sorted based on the expression level of CD146. The sorted undifferentiated bronchial epithelial cells were cultured and monitored during the differentiation process until obtention of a fully differentiated epithelium (n = 3). The sorted differentiated bronchial epithelial cells were used to perform RNA-Seq experiments (n = 4).
Results
We showed that CD146 is highly expressed in severe asthma patients compared to healthy controls both at mRNA and protein levels in differentiated epithelium. Then, we have shown that CD146 expression is not ubiquitous in the differentiated bronchial epithelium. Cell sorting and RNA-seq experiments demonstrated that CD146 is mostly expressed by the basal epithelial cells in the differentiated epithelium. Finally, morphological analysis revealed that CD146 seems to play a role in the bronchial epithelium differentiation process. Indeed, fully differentiated epithelium obtained from CD146+ and CD146− sorted undifferentiated bronchial epithelial cells were different in morphology and cell composition.
Conclusion
Our results suggest that CD146 is only expressed by basal cells of the bronchial epithelium and supports an important role in the differentiation of this epithelium. Moreover, we demonstrated that CD146is overexpressed in severe asthma, suggesting a possible role of this molecule in this disease notably during repair epithelial process.
期刊介绍:
La Revue des Maladies Respiratoires est l''organe officiel d''expression scientifique de la Société de Pneumologie de Langue Française (SPLF). Il s''agit d''un média professionnel francophone, à vocation internationale et accessible ici.
La Revue des Maladies Respiratoires est un outil de formation professionnelle post-universitaire pour l''ensemble de la communauté pneumologique francophone. Elle publie sur son site différentes variétés d''articles scientifiques concernant la Pneumologie :
- Editoriaux,
- Articles originaux,
- Revues générales,
- Articles de synthèses,
- Recommandations d''experts et textes de consensus,
- Séries thématiques,
- Cas cliniques,
- Articles « images et diagnostics »,
- Fiches techniques,
- Lettres à la rédaction.